Health ❯ Healthcare ❯ Pharmaceuticals

Medications

GLP-1 Drugs GLP-1 Receptor Agonists Weight Loss Drugs Alzheimer's Disease Wegovy Weight Loss Tirzepatide Weight Loss Injections GLP-1 Medications Semaglutide Presbyopia Treatment Finasteride Weight Loss Treatments Weight-loss Injections Dementia Treatments GLP-1 Medicines Glifozine Topical Treatments Generic Medications GLP-1s Cyclobenzaprine Probiotics Paxlovid Eye Drops Novo Nordisk Ineffective Treatments Regulation GLP-1 medications Evolocumab Injectable Ethanol Patents Tacrolimus Nearlea Tirzepatida Venlafaxine Wegovy and Ozempic GLP-1 Agonists Migraine Treatment Opioid Overdose Prevention GLP-1 Analogues Varenicline Blood Pressure Drugs GLP-1 Leucovorin Obesity and Diabetes Treatment Diabetes Metformin

Yahoo Finance Highlights Merck and Bristol Myers as Value Plays Outside the GLP-1 Surge

Eli Lilly trades near a 50 P/E with its two GLP-1 drugs already supplying more than half of revenue.

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

White House Clinches GLP-1 Price Deal as Lilly Sets Zepbound and Pill Pricing

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Costco to Offer Ozempic and Wegovy for $499 a Month to Self-Pay Members Nationwide

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

Australian Study Finds Contraception Gaps and Pregnancies After GLP-1 Weight-Loss Prescriptions

FDA Approves First New Fibromyalgia Treatment in 15 Years

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy